|
Orthologous residues
|
|
BCLAF1 (human): S531‑p, BCLAF1 iso3 (human): S529‑p, BCLAF1 iso4 (human): S358‑p, BCLAF1 (mouse): S529‑p, BCLAF1 (rat): S531‑p, BCLAF1 iso3 (rat): S672‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
mass spectrometry, multiple reaction monitoring (MRM)
|
|
Relevant cell lines - cell types - tissues:
293 (epithelial)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
human
|
|
Upstream Regulation
|
|
Potential in vivo enzymes for site:
|
|
Type
|
Enzyme
|
Evidence
|
Notes
|
|
KINASE
|
GSK3B (human)
|
modification site within consensus motif
|
|
|
KINASE
|
GSK3B (human)
|
inhibition of upstream enzyme
|
|
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
lithium
|
|
|
|
decrease
|
|
|